Progress in clinical diagnosis and treatment of gallbladder cancer
10.3760/cma.j.cn112139-20220223-00076
- VernacularTitle:胆囊癌临床诊疗的新进展
- Author:
Ziyi YANG
1
;
Shilei LIU
;
Chen CAI
;
Ziyou WU
;
Yichen XIONG
;
Maolan LI
;
Xiangsong WU
;
Zhiwei QUAN
;
Wei GONG
Author Information
1. 上海交通大学医学院附属新华医院普外科 上海市胆道疾病研究重点实验室 上海市胆道疾病研究中心 上海交通大学医学院胆道疾病研究所,上海 200092
- Keywords:
Gallbladder neoplasms;
Clinical trial;
Diagnosis;
Treatment;
Progress
- From:
Chinese Journal of Surgery
2022;60(8):784-791
- CountryChina
- Language:Chinese
-
Abstract:
Due to the lack of effective early diagnosis and treatment, gallbladder cancer(GBC) remains a malignant tumor with extremely high malignancy and poor prognosis. Therefore, high quality studies are required to break through the bottleneck in GBC diagnosis and treatment. This article reviewed the domestic and foreign GBC research published in 2021, presenting a comprehensive summary of the important advances in the field of clinical diagnosis and treatment. Latest epidemiological data and risk factors, emerging diagnostic methods of peripheral blood laboratory tests and imaging, new pathologic classification system, hot topics and controversies of surgical treatment as well as the dynamics of systemic treatment of GBC are reviewed in the article. The present findings may contribute to a more efficient means of diagnosis and treatment for GBC and hold the promise of improved outcomes for patients with GBC.